September 16, 2025Open Access

Real-World Assessment of Current Migraine Prophylaxis in Egypt: A Multicenter National Study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Cross-sectional study highlights low adherence to migraine prophylactic treatments in patients, suggesting antidepressants improve compliance.

Only 30.4% of migraine patients adhered to their prophylactic treatment regimen, highlighting a significant issue.
Patients on polytherapy regimens showed reduced migraine duration and better scores on MIDAS and VAS measures.
Antiepileptic drugs accounted for 40% of prescribed prophylactic treatments among the studied population.
Utilizing antidepressants emerged as a key predictor for adherence among migraine patients in Egypt.

Al‐Azayem et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Cross-sectional study highlights low adherence to migraine prophylactic treatments in patients, suggesting antidepressants improve compliance.